SUBSEQUENT EVENTS	12 Months Ended
May 31, 2013
SUBSEQUENT EVENTS:
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated all events or transactions that occurred after May 31, 2013 through the date of this filing in accordance with FASB ASC 855 “Subsequent Events”. Except as noted below, the Company is not aware of any subsequent events which would require recognition or disclosure in the financial statements. On August 5, 2013, the Company filed a Certificate of Amendment with the Nevada Secretary of State to change its name to Rambo Medical Group, Inc. (the “Name Change”) and to effect a 1:100 reverse stock split (the “Reverse Split”). The effective date of the Name Change and Reverse Split was August 9, 2013 (the “Effective Date”). On the Effective Date, every 100 outstanding shares of the Company’s common became one share of common stock. No fractional shares will be issued in connection with the Reverse Split. The Reverse Split did not affect the Company’s authorized capitalization which remains at 300,000,000 shares of common stock, $0.00001 par value per share, and 10,000,000 shares of blank check preferred stock, $0.00001 par value per share.

SUBSEQUENT EVENTS

12 Months Ended

May 31, 2013

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated all events or transactions that occurred after May 31, 2013 through the date of this filing in accordance with FASB ASC 855 “Subsequent Events”. Except as noted below, the Company is not aware of any subsequent events which would require recognition or disclosure in the financial statements.

On August 5, 2013, the Company filed a Certificate of Amendment with the Nevada Secretary of State to change its name to Rambo Medical Group, Inc. (the “Name Change”) and to effect a 1:100 reverse stock split (the “Reverse Split”). The effective date of the Name Change and Reverse Split was August 9, 2013 (the “Effective Date”). On the Effective Date, every 100 outstanding shares of the Company’s common became one share of common stock. No fractional shares will be issued in connection with the Reverse Split. The Reverse Split did not affect the Company’s authorized capitalization which remains at 300,000,000 shares of common stock, $0.00001 par value per share, and 10,000,000 shares of blank check preferred stock, $0.00001 par value per share.